Short Survey
Genetics of rheumatoid arthritis: A new boost is needed in Latin American populations
Date
2016Registration in:
56, 2, 171-177
04825004
Author
Castro-Santos P.
Díaz-Peña R.
Institutions
Subjects
Related items
Showing items related by title, author, creator and subject.
-
Genomics, proteomics and metabolomics: Their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers
Castro-Santos P.; Laborde C.M.; Díaz-Peña R. (Clinical and Experimental Rheumatology S.A.S., 2015) -
The role of protein SUMOylation in rheumatoid arthritis
Dehnavi S.; Sadeghi M.; Johnston T.P.; Barreto G.; Shohan M.; Sahebkar A. (Academic Press, 2019) -
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis
Burmester, Gerd R.; McInnes, Iain B.; Kremer, Joel; Miranda, Pedro; Korkosz, Mariusz; Vencovsky, Jiri; Rubbert-Roth, Andrea; Mysler, Eduardo; Sleeman, Matthew A.; Godwood, Alex; Sinibaldi, Dominic; Guo, Xiang; White, Wendy I.; Wang, Bing; Wu, Chi Yuan; Ryan, Patricia C. (BMJ Publishing Group, 2017)Objectives: Despite the therapeutic value of current rheumatoid arthritis (RA) treatments, agents with alternative modes of action are required. Mavrilimumab, a fully human monoclonal antibody targeting the granulocyte-macrophage ...